tiprankstipranks
New Century Healthcare Holding Co. Ltd. (HK:1518)
:1518
Hong Kong Market
Want to see HK:1518 full AI Analyst Report?

New Century Healthcare Holding Co. Ltd. (1518) AI Stock Analysis

1 Followers

Top Page

HK:1518

New Century Healthcare Holding Co. Ltd.

(1518)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - Gpt-5.6Sol)
Rating:44Neutral
Price Target:
HK$0.21
▼(-11.67% Downside)
Action:Reiterated
Date:08/08/26
The score is held down primarily by weak and volatile financial performance (2025 revenue decline and a return to net losses, alongside a sharp cash flow slowdown) and bearish technicals (price below key moving averages and negative MACD). A high dividend yield provides some valuation support, but losses (negative P/E) limit upside in the overall assessment.
Positive Factors
Manageable Leverage
Moderate leverage and positive equity provide a financial cushion for the healthcare-services business. This supports ongoing operations and preserves some capacity to manage weaker periods, although sustained losses could still erode that cushion over time.
Negative Factors
Revenue Contraction
A material revenue decline weakens the scale and earnings base of the medical-services operation. If demand or service activity does not recover, lower revenue can reduce operating leverage, constrain reinvestment, and make a return to consistent profitability more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Moderate leverage and positive equity provide a financial cushion for the healthcare-services business. This supports ongoing operations and preserves some capacity to manage weaker periods, although sustained losses could still erode that cushion over time.
Read all positive factors

New Century Healthcare Holding Co. Ltd. (1518) vs. iShares MSCI Hong Kong ETF (EWH)

New Century Healthcare Holding Co. Ltd. Business Overview & Revenue Model

Company Description
New Century Healthcare Holding Co. Limited functions as an investment enterprise, providing medical services specifically designed for women and children throughout the People's Republic of China. Its principal activities include specialized care ...
How the Company Makes Money
The company generates revenue primarily by delivering healthcare services through its medical facilities (e.g., hospitals/clinics) and charging patients and/or payors for clinical services. Key revenue streams typically include fees from inpatient...

New Century Healthcare Holding Co. Ltd. Financial Statement Overview

Summary
Fundamentals are mixed but skew weak: 2025 results deteriorated materially with revenue down ~20% YoY and a swing back to a sizable net loss and negative operating profit. Cash flow also stepped down sharply in 2025 (FCF down ~86% YoY), though it remained positive. The balance sheet is comparatively steadier with moderate leverage and positive equity, but profitability volatility and negative ROE in weak years reduce confidence.
Income Statement
38
Negative
Balance Sheet
56
Neutral
Cash Flow
44
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue600.10M846.50M933.07M636.46M632.57M
Gross Profit175.88M344.96M407.09M202.14M198.74M
EBITDA3.28M170.68M234.18M-209.54M41.78M
Net Income-115.31M47.38M84.16M-297.73M-101.46M
Balance Sheet
Total Assets745.64M939.13M944.39M901.38M1.27B
Cash, Cash Equivalents and Short-Term Investments283.58M354.52M304.31M226.08M223.84M
Total Debt166.31M185.83M206.07M217.02M280.24M
Total Liabilities391.51M430.26M492.63M540.03M586.66M
Stockholders Equity428.97M553.83M522.28M438.26M737.46M
Cash Flow
Free Cash Flow8.29M114.10M148.21M66.16M9.10M
Operating Cash Flow17.93M135.92M158.92M76.28M22.25M
Investing Cash Flow-62.61M-21.03M-8.64M-23.07M-15.74M
Financing Cash Flow-79.16M-65.18M-73.07M-57.26M-79.84M

New Century Healthcare Holding Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.24
Price Trends
50DMA
0.29
Negative
100DMA
0.41
Negative
200DMA
0.52
Negative
Market Momentum
MACD
-0.02
Negative
RSI
44.80
Neutral
STOCH
92.56
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1518, the sentiment is Negative. The current price of 0.24 is below the 20-day moving average (MA) of 0.25, below the 50-day MA of 0.29, and below the 200-day MA of 0.52, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 44.80 is Neutral, neither overbought nor oversold. The STOCH value of 92.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1518.

New Century Healthcare Holding Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$635.35M5.816.35%10.00%-0.27%29.73%
67
Neutral
HK$320.38M9.784.28%8.25%-2.78%-24.77%
62
Neutral
HK$469.86M-145.50-0.41%3.16%-101.02%
58
Neutral
HK$292.26M10.533.54%3.90%9.74%32.37%
56
Neutral
HK$1.23B84.760.48%1.02%-3.26%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
44
Neutral
HK$121.54M-0.76-34.98%8.88%-23.52%-226.85%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1518
New Century Healthcare Holding Co. Ltd.
0.25
-0.52
-67.66%
HK:1419
Human Health Holdings Ltd.
0.77
-0.27
-25.96%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.90
-0.06
-3.21%
HK:3869
Hospital Corporation of China Ltd
3.40
-3.39
-49.93%
HK:3886
Town Health International Medical Group Ltd.
0.18
-0.08
-31.13%
HK:0722
UMP Healthcare Holdings Limited
0.40
-0.06
-13.23%

New Century Healthcare Holding Co. Ltd. Corporate Events

New Century Healthcare Swings to Deeper Interim Loss on Falling Patient Volumes and Regulatory Provision
Aug 31, 2026
New Century Healthcare reported interim revenue of RMB249.0 million for the six months ended June 30, 2026, down from RMB304.5 million a year earlier, as both outpatient and inpatient medical service income declined. Outpatient revenue fell 16.5% ...
New Century Healthcare flags wider interim loss on provision for frozen bank accounts
Aug 28, 2026
New Century Healthcare Holding Co. Ltd. warned that it expects to post a loss attributable to owners of about RMB85 million for the six months ended June 30, 2026, widening from a loss of roughly RMB65.2 million a year earlier. The interim figures...
New Century Healthcare Sets Board Meeting to Approve Interim Results
Aug 18, 2026
New Century Healthcare Holding Co. Ltd. has scheduled a board meeting for August 31, 2026 to review and approve its interim results for the six months ended June 30, 2026. The session will also address other business matters, signaling routine gov...
New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe
Aug 14, 2026
New Century Healthcare disclosed that in late April 2026 some, but not all, of its bank accounts were frozen in connection with an investigation by the Beijing Mentougou Supervisory Committee involving one of its cooperative partners. About RMB218...
New Century Healthcare Flags Losses and Strategic Review at Chengdu Hospital
Jul 3, 2026
New Century Healthcare Holding Co. Limited has disclosed mounting challenges at its Chengdu New Century Women’s and Children’s Hospital, citing the current economic environment, falling birth rates and fierce market competition as key ...
New Century Healthcare Refreshes Board With Independent Healthcare Investor
Jul 2, 2026
New Century Healthcare Holding Co. Ltd. announced changes to its board, with non-executive director Mr. Wang Siye resigning effective June 30, 2026, citing work adjustments. The board noted that Mr. Wang has no disagreements with directors and exp...
New Century Healthcare Refines Board and Committee Structure
Jul 2, 2026
New Century Healthcare Holding Co. Ltd. has updated its board structure effective July 2, 2026, confirming Jason Zhou as chairman and chief executive officer alongside senior vice presidents overseeing operations and finance. The board now compris...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 08, 2026